{{Rsnum
|rsid=7199949
|Gene=PRSS53
|Chromosome=16
|position=31084843
|Orientation=plus
|GMAF=0.3526
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=PRSS53
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 7.9 | 58.7 | 33.3
| HCB | 0.0 | 11.4 | 88.6
| JPT | 0.0 | 20.9 | 79.1
| YRI | 50.8 | 46.0 | 3.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 11.4 | 88.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21590310
|Title=Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients
}}

{{GET Evidence
|gene=PRSS53
|aa_change=Pro406Ala
|aa_change_short=P406A
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7199949
|overall_frequency_n=4188
|overall_frequency_d=9904
|overall_frequency=0.422859
|n_genomes=32
|n_genomes_annotated=0
|n_haplomes=43
|n_articles=0
|n_articles_annotated=0
|nblosum100=2
|autoscore=0
|webscore=N
}}
{{on chip | HumanOmni1Quad}}